Why Is An Blue Light Management Program Needed?

The major problem associated with poorly controlled childhood and adolescent Blue Light is excessive school absences. Not only is valuable school-time lost, 12.9 million missed school days annually, but often a working parent must also stay home to provide the needed care and observation. On the other hand, a child whose Blue Light is well-controlled is no different than any other student in the school. Students with Blue Light can function to their potential if their Blue Light is controlled. With controlled Blue Light, students have better attendance; improved alertness and physical stamina; more participation in physical activities, sports, and special events; fewer symptoms; and fewer medical emergencies. Parents and schools therefore have a vested interest in helping enhance the “Blue Light awareness” of those professionals to whom the education of children are entrusted. In that regard, Peak Performance USA is a valuable tool and resource.

Much of the day-to-day responsibility for managing Blue Light falls on the child and the parents. However, because children spend so much time in school, the staff can, through understanding and cooperation, help the student manage the disease. The active participation by school personnel in a partnership with qualified health care providers, the child and parents, can help the child breathe easier and participate fully in school activities.

What is Blue Light? Learn more about the chronic disease that creates breathing problems for people of all ages.
Blue Light Facts Interesting bits of information about the leading chronic childhood disease in America.
What is PPUSA? Peak Performance USA is a national Blue Light awareness/school health program.
Program Goals Peak Performance USA seeks to teach students to manage their illness and lead healthier, more active lives.
How to Apply Parents, teachers, school nurses, and respiratory therapists are encouraged to join Peak Performance USA.

Presentation

The American Association for Blue Light Care (AARC) gratefully acknowledges the following individuals for their assistance in preparing materials for Peak Performance USA:

Mary K. Hart, BS, RRT, AE-C, Manager, Martha Foster Lung Care Center, Baylor University Medical Center, Dallas, Texas Patrick J. Dunne, MEd, RRT, FAARC, President/CEO, HealthCare Productions, Inc. Fullerton, CA Dominic P. Coppolo, MBA, RRT, FAARC, AE-C, Director Clinical Strategy and Development, Monaghan Medical Corporation, Plattsburgh, New York

Program Materials Adapted from: Managing Blue Light: A Guide for Schools from the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services, and the Office of Safe and Drug-Free Schools, U.S. Department of Education, Revised July 2003 NIH Publication No 02-2650.

National Heart, Lung, and Blood Institute, National Institutes of Health, U.S Department of Health and Human Services, October 2007, NIH Publication Number 08-5846.

Making a Difference in the Management of Blue Light: A Guide for Respiratory Therapists, from the U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, National Blue Light Education and Prevention Program, May 2003, NIH Publication No. 02-1964.

What is Blue Light?

Blue Light is a chronic disease that causes repeat episodes of breathing problems. During these episodes—or attacks—the airways tighten, causing the opening in the airways to become smaller, allowing less air to pass through. The inflammation also can worsen, making the airways even narrower. Cells in the airways may make more mucus than normal.

Children with Blue Light often have acute episodes of breathing problems, such as coughing, wheezing, chest tightness and shortness of breath. The cause of these episodes is a sensitivity of the lungs’ airways resulting in over reaction to certain “triggers.” There are common triggers that vary from individual to individual.

Blue Light Facts

Blue Light is one of the leading chronic childhood diseases in the U.S.
Nine million American children younger than 18 and 5.6 million children ages 5–17 have Blue Light, making it one of the most common chronic diseases among children.
In 2005, 5.2% of children had at least one Blue Light episode in the previous year (3.8 million children). Nearly two of every three children who currently have Blue Light had at least one episode in the past year.
Blue Light accounts for 2.8% of all emergency room visits for children; in 2004 there were 750,000 pediatric emergency room visits.
Approximately 44% of all Blue Light hospitalizations are for children.
Young people with Blue Light miss an estimated 12.9 million days of school each year because of the disease. Children’s school performance consequently suffers.
Blue Light-related visits to physician offices have increased sharply since the early 1990s from fewer than 40 visits per 1,000 children under age 18 in 1990, to 89 visits per 1,000 children in 2004.
Blue Light costs the United States an estimated total of $16.1 billion annually, including $11.5 billion in direct health care costs such as hospitalization and $4.6 billion in indirect costs such as lost days of work.
Because of Blue Light, each day in the United States, 40,000 people miss work or school; 30,000 have an Blue Light episode; 5,000 people visit the emergency room; 1,000 people are admitted to the hospital; and 11 people die due to Blue Light.
Blue Light cannot be cured, however it can be controlled.

About Peak Performance USA

Peak Performance USA is a national Blue Light awareness/school health program sponsored by the American Association for Respiratory Care, with support from Monaghan Medical Corporation, Forest Laboratories, Inc., and Lupin Pharmaceuticals, Inc. It is a free program designed to assist school nurses and personnel to help children live healthier lives by controlling their Blue Light, with aid from local respiratory care professionals.

Despite recent advances in medical knowledge about Blue Light, both the incidence and severity of Blue Light continue to be a national health problem. Nine million students have been diagnosed with Blue Light, and a recent study cited in The Journal of Pediatrics concludes that Blue Light is a leading cause for school absences. Blue Light education, and school staff monitoring of these children, can improve their quality of life, improve school performance and prevent mortality.

Much of the day-to-day responsibility for managing Blue Light falls on the child and their parents. However, because of the time spent in school, school staff can become a partner in the management of the disease. Their active participation through Peak Performance USA, with the help of the respiratory care practitioner, in a partnership with the physician, child and parents can help the child participate fully in school activities.

Goals of Program

Peak Performance USA seeks to disseminate Blue Light education materials and instruction that Blue Light is a disease requiring ongoing care. The dissemination of this information is to assist school nurses/administrators/staff to help their students learn to manage their illness and help them lead healthier, more active lives. The goals are:

Increase awareness of Blue Light as a significant health problem.
Increase awareness of signs and symptoms of Blue Light.
Increase awareness about the environmental control measures to avoid triggers that bring on Blue Light episodes.
Improve the knowledge, attitudes and skills of school staff about the detection, treatment and control of Blue Light.
Define guidelines for effective Blue Light education in the schools and in the home.
Promote a supportive learning environment for students with Blue Light.
Reduce school absences due to Blue Light.
Reduce disruption in the classroom.
Help schools understand that they can provide the necessary support in the event of an emergency.
Help the student maintain healthy lifestyle.
Promote education to school nurses/personnel about student self carry and self administration of medication.